SPL 3.13% 9.9¢ starpharma holdings limited

Ann: Starpharma and Medicxi Partnership Petalion Therapeutics, page-46

  1. 3,300 Posts.
    lightbulb Created with Sketch. 777
    You conveniently left out the fact that the investment is to be in staged tranches.

    For all we know the initial tranche for early stage research could be as little as $1m with the balance to potentially tipped in over 15 years of development.

    All I know is Starpharma have chosen to give away their IP in exchange for a minority equity stake in a new non-listed entity controlled by others, rather than demanding a cash up front licence fee.

    That’s a fact.

    Outmanoeuvred IMO.
    Last edited by sarge17: 08/04/24
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
9.9¢
Change
0.003(3.13%)
Mkt cap ! $40.82M
Open High Low Value Volume
9.8¢ 10.0¢ 9.7¢ $50.87K 510.1K

Buyers (Bids)

No. Vol. Price($)
1 180 9.8¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 101919 3
View Market Depth
Last trade - 15.20pm 05/07/2024 (20 minute delay) ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.